Summary | US drug giant Merck (NYSE: MRK) has become the latest
major pharmaceuticals company to pair up with a Chinese
partner, in this case US-listed Simcere Pharmaceutical (NYSE:
SCR), in a bid to take advantage of huge new opportunities as
China rolls out a new national healthcare safety net. Financial
terms of the tie-up aren't given, ...
major pharmaceuticals company to pair up with a Chinese
partner, in this case US-listed Simcere Pharmaceutical (NYSE:
SCR), in a bid to take advantage of huge new opportunities as
China rolls out a new national healthcare safety net. Financial
terms of the tie-up aren't given, ...
youngchinabiz.com | 19 April 2016